Added by | mollevi |
---|---|
Group name | EquipeCG |
Item Type | Note |
Note | Michaelson, M Dror |
Date Added | 2018/07/20 - 10:05:58 |
Date Modified | 2018/07/20 - 10:05:58 |
Parent item | Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer |